<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941110-1-00101</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4702 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <TABLE>  <!-- PJG tableformat 7,L2,tp0,i1,s100,10,10,10,10,10,10 -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=95 g=1 f=1 --> &blank; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Control period  <!-- PJG 007 0150 intable --> 1Class I substances in groups I and III (percent) <!-- PJG 007 0150 intable --> 1Class I substances in group II (percent) <!-- PJG 007 0150 intable --> 1Class I substances in group IV (percent) <!-- PJG 007 0150 intable --> 1Class I substances in group V (percent) <!-- PJG 007 0150 intable --> 1Class I substances in group VI (percent) <!-- PJG 007 0150 intable --> 1Class I substances in Group VII (percent) <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> 1994 <!-- PJG 007 0104 intable --> 25 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 50 <!-- PJG 007 0104 intable --> 50 <!-- PJG 007 0104 intable --> 100 <!-- PJG 007 0104 intable --> 100 <!-- PJG 0012 frnewline -->  1995 <!-- PJG 007 0104 intable --> 25 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 15 <!-- PJG 007 0104 intable --> 30 <!-- PJG 007 0104 intable --> 100 <!-- PJG 007 0104 intable --> 100 <!-- PJG 0012 frnewline -->  1996 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 100 <!-- PJG 007 0104 intable --> 0 <!-- PJG 0012 frnewline -->  1997 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 100 <!-- PJG 007 0104 intable --> 0 <!-- PJG 0012 frnewline -->  1998 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 100 <!-- PJG 007 0104 intable --> 0 <!-- PJG 0012 frnewline -->  1999 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 100 <!-- PJG 007 0104 intable --> 0 <!-- PJG 0012 frnewline --> 2000 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 100 <!-- PJG 007 0104 intable --> 0 <!-- PJG 0012 frnewline -->  2001 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG 007 0104 intable --> 0 <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG -->  <!-- PJG STAG 4702 -->   <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;82.8  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Grant and phased reduction of baseline production and consumption allowances for class II controlled substances. [Reserved] <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;82.9  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Availability of allowances in addition to baseline production allowances.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a) Every person apportioned baseline production allowances for class I controlled substances under &sect;82.5 (a) through (e) of this subpart is also granted Article 5 allowances equal to: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (1) 15 percent of his baseline production allowances for class I, Group II controlled substances listed under &sect;82.5 of this subpart for each control period beginning January 1, 1994 until January 1, 2003; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (2) 10 percent of his baseline production allowance listed for class I, Group I, Group III, Group IV, and Group V controlled substances listed under &sect;82.5 of this subpart for each control period ending before January 1, 1996; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (3) 15 percent of his baseline production allowances for class I, Group I, Group III, Group IV, and Group V controlled substances listed under &sect;82.5 of this subpart for each control period beginning January 1, 1996 until January 1, 2006.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (b) Effective January 1, 1995, a person allocated Article 5 allowances may produce class I controlled substances for export to Article 5 countries as under &sect;82.11 and transfer Article 5 allowances as under &sect;82.12. In addition, a company may also increase or decrease its Article 5 allowances by trading with another Party to the Protocol according to the provisions under this paragraph of this section. A nation listed in Appendix C to this subpart (Parties to the Montreal Protocol) must agree either to transfer to the person for the current control period some amount of Article 5 production that the nation is permitted under the Montreal Protocol or to receive from the person for the current control period some amount of Article 5 production that the person is permitted under this subpart.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            